These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14643836)

  • 1. Behavioral and physiological effects of cocaine in humans following triazolam.
    Haga JL; Baker RW; Rush CR
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):383-92. PubMed ID: 14643836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral pharmacological similarities between methylphenidate and cocaine in cocaine abusers.
    Rush CR; Baker RW
    Exp Clin Psychopharmacol; 2001 Feb; 9(1):59-73. PubMed ID: 11519636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
    Rush CR; Kollins SH; Pazzaglia PJ
    Exp Clin Psychopharmacol; 1998 Feb; 6(1):32-44. PubMed ID: 9526144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute behavioral effects and abuse potential of trazodone, zolpidem and triazolam in humans.
    Rush CR; Baker RW; Wright K
    Psychopharmacology (Berl); 1999 Jun; 144(3):220-33. PubMed ID: 10435388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine-like subjective effects of nicotine are not blocked by the D1 selective antagonist ecopipam (SCH 39166).
    Chausmer AL; Smith BJ; Kelly RY; Griffiths RR
    Behav Pharmacol; 2003 Mar; 14(2):111-20. PubMed ID: 12658071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects in humans after repeated administrations of zolpidem and triazolam.
    Stoops WW; Rush CR
    Am J Drug Alcohol Abuse; 2003 May; 29(2):281-99. PubMed ID: 12765207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute behavioral and physiological effects of modafinil in drug abusers.
    Rush CR; Kelly TH; Hays LR; Baker RW; Wooten AF
    Behav Pharmacol; 2002 Mar; 13(2):105-15. PubMed ID: 11981223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
    Rush CR; Baker RW; Rowlett JK
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):22-36. PubMed ID: 10743902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women.
    Babalonis S; Lile JA; Martin CA; Kelly TH
    Behav Pharmacol; 2011 Sep; 22(5-6):441-9. PubMed ID: 21808190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability.
    Evans SM; Funderburk FR; Griffiths RR
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1246-55. PubMed ID: 2262904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined discriminative stimulus effects of midazolam with other positive GABAA modulators and GABAA receptor agonists in rhesus monkeys.
    McMahon LR; France CP
    Psychopharmacology (Berl); 2005 Apr; 178(4):400-9. PubMed ID: 15765255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute physiological and behavioral effects of oral cocaine in humans: a dose-response analysis.
    Rush CR; Baker RW; Wright K
    Drug Alcohol Depend; 1999 Jun; 55(1-2):1-12. PubMed ID: 10402144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A follow-up study of the acute behavioral effects of benzodiazepine-receptor ligands in humans: comparison of quazepam and triazolam.
    Rush CR; Ali JA
    Exp Clin Psychopharmacol; 1999 Aug; 7(3):257-65. PubMed ID: 10472514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine.
    Marks KR; Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    J Clin Psychopharmacol; 2016 Jun; 36(3):213-21. PubMed ID: 27043121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo.
    Smith BJ; Bickel WK
    Drug Alcohol Depend; 2001 Feb; 61(3):249-60. PubMed ID: 11164689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women.
    Babalonis S; Lile JA; Martin CA; Kelly TH
    Psychopharmacology (Berl); 2011 Jun; 215(3):429-39. PubMed ID: 21350928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The negative GABA(A) modulator methyl beta-carboline-3-carboxylate attenuates the behavioral effects of the positive GABA(A) modulators triazolam and pregnanolone in rhesus monkeys.
    McMahon LR; France CP
    Psychopharmacology (Berl); 2001 Nov; 158(3):289-96. PubMed ID: 11713619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens.
    Reissig CJ; Carter LP; Johnson MW; Mintzer MZ; Klinedinst MA; Griffiths RR
    Psychopharmacology (Berl); 2012 Sep; 223(1):1-15. PubMed ID: 22526529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
    Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C
    Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.